SCHEMBL24352663

SCHEMBL24352663

NCc1ccccc1-c1cccnn1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.47
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ ATR Q13535 1/20 0.38
▸ CASP6 P55212 1/20 0.38
▸ PNMT P11086 2/20 0.36
▸ HTR2C P28335 5/20 0.36
▸ HTR2A P28223 2/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.35
▸ PDE9A O76083 1/20 0.35
▸ GOT1 P17174 1/20 0.34
▸ P2RX7 Q99572 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ ALOX5AP P20292 1/20 0.32
▸ FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29473282 0.98 DPP4 (0.46) DPP4PRMT5WDR77ATRCASP6
SCHEMBL24352736 0.79 CASP6 (0.42) CASP6HTR2CHTR2APDE9AGOT1
SCHEMBL28680308 0.79 HTR2C (0.40) CASP6HTR2CHTR2APDE9AHTR2B
SCHEMBL28149684 0.78 CASP6 (0.51) PRMT5WDR77CASP6LOXL2P2RX7
SCHEMBL24352277 0.77 LTA4H (0.45) CASP6HTR2CHTR2APDE9AHTR2B
SCHEMBL3790206 0.77 KDM4E (0.50) DPP4ATRLOXL2
SCHEMBL29496884 0.77 KDM4E (0.50) DPP4ATRLOXL2
SCHEMBL3102409 0.75 ALDH1A1 (0.54) ATRHTR2CHTR2AGOT1
SCHEMBL29943503 0.75 ALDH1A1 (0.54) ATRHTR2CHTR2AGOT1
Ethylene SCHEMBL27759749 0.74 DPP4 (0.47) DPP4ATRLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103002897-B Certain amino-pyridazines, compositions thereof, and methods of use thereof 赛特凯恩蒂克公司 2017-06-09 — — CN claimed
US-20220119395-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119395-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 DPP4 651/4885PRMT5 4070/4885WDR77 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback